Forward Deployed Software Engineer| Solution Architect
EmaSalary not specified
- Full Time
- Mid-level (3 to 4 years), Senior (5 to 8 years)
Not SpecifiedCompensation
Mid-level (3 to 4 years), Senior (5 to 8 years)Experience Level
Full TimeJob Type
UnknownVisa
Pharmaceutical, ManufacturingIndustries
Requirements
Candidates should possess a Bachelor’s degree in Engineering, Computer Science, or a related field, with a minimum of 5 years of experience in the Life Sciences industry and at least 5 years’ experience in Emerson Syncade MES, or 8+ years’ experience in the Life Sciences industry with at least 8 years’ experience in Emerson Syncade MES. They should have at least 5 years of direct experience designing, building, deploying, and supporting automation and execution systems (Syncade, DeltaV, PI Data historian, etc.) in regulated manufacturing environments, and demonstrate strong domain expertise in automation and execution systems.
Responsibilities
The EMES Developer will be responsible for development, maintenance, and support of the global Enterprise Manufacturing Execution Systems (EMES) solution, partnering with IT and Business teams to understand requirements and develop solutions. They will design, build, test, and deliver standard and custom EMES capabilities, provide support to minimize disruption to manufacturing, contribute to knowledge management, promote compliance with data integrity and computer system validation requirements, and identify opportunities for continuous improvement.
Skills
Emerson Syncade MES
Automation
Execution Systems
DeltaV
PI Data Historian
Data Integrity
Computer System Validation
Manufacturing
Requirements Gathering
Solution Design
Support
Maintenance
Development
Testing
Domain Expertise
Bristol-Myers Squibb
Develops and delivers biopharmaceutical medicines
About Bristol-Myers Squibb
Bristol Myers Squibb (BMS) develops and delivers medicines aimed at treating serious diseases, focusing on areas like cancer, autoimmune diseases, and heart conditions. The company conducts extensive research and development to create new drugs, which are sold after receiving regulatory approval. BMS also produces generic drugs, offering affordable alternatives that meet the same quality standards as their branded counterparts. What sets BMS apart from competitors is its dual focus on both innovative and generic medicines, enhancing access to healthcare. The company's goal is to improve patient outcomes while maintaining a commitment to sustainability and corporate responsibility.
Key Metrics
New York City, New YorkHeadquarters
1887Year Founded
$33,706.1MTotal Funding
IPOCompany Stage
Biotechnology, HealthcareIndustries
10,001+Employees